Area of research
Pharmacology · Dermatology
Research interest
Research focused on Toxic epidermal necrolysis and Dermatology, with related work in Mycosis fungoides, Vemurafenib, Intertriginous. Notable publications include 'Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States', 'Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10', and 'Large-cell transformation of mycosis fungoides–differential diagnosis with implications for clinical management: A consensus statement of the US Cutaneous Lymphoma Consortium'.
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10
Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation—A retrospective chart review
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States
Systemic drug-related intertriginous and flexural exanthema from radio contrast media: A series of 3 cases
Practical Management of CD30+ Lymphoproliferative Disorders
Large-cell transformation of mycosis fungoides–differential diagnosis with implications for clinical management: A consensus statement of the US Cutaneous Lymphoma Consortium
Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma
Recognizing large-cell transformation of mycosis fungoides
Atypical Presentation of Exophytic Herpes Simplex Virus Type 2 With Concurrent Cytomegalovirus Infection